文献速递消化道肿瘤放疗

不适合手术的早期食管鳞状细胞癌患者单纯大分割放射治疗后的结局:一项回顾性单中心分析

Outcomes following hypofractionated radiation therapy alone for surgically unfit early esophageal squamous cell carcinoma patients; a retrospective single center analysis.
PubMed 文献 · Radiother Oncol · 2023-11-04

该回顾性单中心分析评估了60例cT1-2N0食管鳞状细胞癌患者接受单纯大分割放疗(54~60 Gy,每次3.0 Gy)的可行性与肿瘤学结局。5年局部控制率、无进展生存率、肿瘤特异性生存率和总生存率分别为81.1%、44.2%、73.7%和54.5%。作者认为单纯大分割放疗可作为不适合手术或放化疗的早期食管鳞状细胞癌患者的可行选择,肿瘤长度<3 cm似乎是不错的适应证。

要点

  • 60例cT1-2N0食管鳞癌接受单纯大分割放疗(54~60 Gy,3.0 Gy/次),5年总生存率54.5%。
  • 5年局部控制率81.1%,肿瘤长度<3 cm与≥3 cm亚组分别为95.7%和72.0%(p=0.053)。
  • ≥2级食管炎44例(73.3%),≥2级食管狭窄5例(8.3%)。

核心结论

  • 单纯大分割放疗具有疗程短的优点,可作为不适合手术切除或放化疗的早期食管鳞状细胞癌患者的可行选择。
  • 肿瘤长度<3 cm似乎是不错的适应证,基于较好的局部控制率和较低的食管毒性发生率。

研究设计与样本

  • 回顾性单中心分析,纳入2004年至2018年接受大分割放疗(54~60 Gy,每次3.0 Gy)的60例cT1-2N0食管鳞状细胞癌患者。

主要发现

  • 5年局部控制率、无进展生存率、肿瘤特异性生存率和总生存率分别为81.1%、44.2%、73.7%和54.5%。
  • Cox回归分析中,肿瘤长度<3 cm与较好的局部控制相关(HR 0.167,p=0.090)。
  • 肿瘤长度<3 cm与≥3 cm亚组的5年局部控制率分别为95.7%和72.0%(p=0.053)。
  • ≥2级食管炎发生在44例(73.3%)患者中,≥2级食管狭窄发生在5例(8.3%)患者中。
  • 肿瘤长度≥3 cm的患者更常发生≥2级食管炎(13/24 vs. 31/36,p=0.006)和≥2级食管狭窄(0/24 vs. 5/36,p=0.056)。

关键数值与推荐

  • 原文未报告指南或共识推荐条款。

临床怎么用

  • 作者认为单纯大分割放疗可作为不适合手术切除或放化疗的早期食管鳞状细胞癌患者的可行选择。
  • 作者认为肿瘤长度<3 cm似乎是不错的适应证,基于较好的局部控制率和较低的食管毒性发生率。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: To report the feasibility of hypofractionated radiation therapy (RT) alone for early stage esophageal squamous cell carcinoma (ESCC) patients. MATERIALS AND METHODS: The oncologic outcomes of 60 cT1-2 N0 ESCC patients who received hypofractionated RT (54 ∼ 60 Gy by 3.0 Gy per fraction) from 2004 to 2018 were retrospectively evaluated. RESULTS: The 5-year rates of local control (LC), progression-free survival, cancer-specific survival, and overall survival were 81.1 %, 44.2 %, 73.7 %, and 54.5 %, respectively. In Cox regression analysis, tumor length < 3 cm was correlated with favorable LC (HR 0.167, p = 0.090), and the 5-year LC rates were 95.7 % and 72.0 % in < 3 cm and ≥ 3 cm subgroups, respectively (p = 0.053). Grade ≥ 2 esophagitis was observed in 44 patients (73.3 %) and grade ≥ 2 esophageal strictures developed in five (8.3 %), respectively. The patients with ≥ 3 cm tumor more frequently suffered from grade ≥ 2 esophagitis (13/24 vs. 31/36, p = 0.006) and grade ≥ 2 esophageal stricture (0/24 vs. 5/36, p = 0.056), respectively. The patients with cT2 tumor suffered from grade ≥ 2 esophagitis more frequently than those with T1 tumor (29/44 vs. 15/16, p = 0.03). CONCLUSIONS: Hypofractionated RT alone, with the merit of short treatment course, could be used as feasible option in treating the early stage ESCC patients who are unfit for surgical resection or chemoradiation. Especially, tumor length < 3 cm seems a good indication of this treatment scheme based on favorable LC rate with low incidence of esophageal toxicities.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Kim K, Oh D, Noh JM, et al. Outcomes following hypofractionated radiation therapy alone for surgically unfit early esophageal squamous cell carcinoma patients; a retrospective single center analysis. Radiother Oncol. 2023. PMID: 37926329. doi:10.1016/j.radonc.2023.109982

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。